Biomarkers /

BAIAP2L1

Back to Biomarkers List
Associated Diseases

Overview

Location [1]
7q21.3-q22.1
Protein [2]
Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1
Synonyms [1]
IRTKS

BAIAP2L1 is altered in 0.31% of all cancers with lung adenocarcinoma, breast invasive ductal carcinoma, glioblastoma, low-grade glioma, NOS, and pancreatic adenocarcinoma having the greatest prevalence of alterations [3].

BAIAP2L1 GENIE Cases - Top Diseases

The most common alterations in BAIAP2L1 are BAIAP2L1-MET Fusion (0.18%) and BAIAP2L1-BRAF Fusion (0.14%) [3].

BAIAP2L1 GENIE Cases - Top Alterations

References

1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20180821. San Francisco CA: Github;2015. https://github.com/biocommons/uta

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.

4. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.